Vanguard Fiduciary Trust
BOLD

Vanguard Fiduciary Trust’s Boundless Bio BOLD Stock Holding History

Vanguard Fiduciary Trust’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Hold
65,136
– – ﹤0.01% 3634
2026
Q1 		$71.7K Buy
+65,136
New +$76.2K ﹤0.01% 3767

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Fiduciary Trust's BOLD Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Boundless Bio (BOLD) position steady in Q2 2026 at 65,136 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

Vanguard Fiduciary Trust first reported a position in BOLD in Q1 2026 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • Vanguard Fiduciary Trust held 65,136 shares of Boundless Bio worth $163K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Boundless Bio share count unchanged in Q2 2026.
  • Boundless Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3634 holding.
  • Vanguard Fiduciary Trust first reported a position in Boundless Bio in Q1 2026 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.